| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |